Advocacy intelligence hub — real-time data for patient organizations
For the treatment of patients with perinatal/infantile-and juvenile-onset hypophosphatasia (HPP)
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Strensiq
Alexion Pharmaceuticals, Inc.